Intervention

Hydrochlorothiazide 12.5mg

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions7

Lead sponsors shown4

Clinical trials

4 shown

Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure ReductionNCT04676399 · 2022-02-08

ACTIVE_NOT_RECRUITING

Phthalates Exposure in Type 2 Diabetic Patients and Diuretic TherapyNCT04242758 · 2019-06-04

Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.NCT03640221 · 2018-09-01

Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term UseNCT01050062 · 2010-01-01

Common conditions

Hypertension3 Chronic Pain1 Diabetes Mellitus, Type 21 Diuretics Drug Reactions1 Glucose Metabolism Disorders1 Renal Function Disorder1 SCS1

Leading sponsors

Boehringer Ingelheim1 Cedars-Sinai Medical Center1 University of Kansas Medical Center1 University of Pisa1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE42

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.